Mystakidou Kyriaki, Tsilika Eleni, Parpa Efi, Katsouda Emmanuela, Galanos Antonis, Vlahos Lambros
Palliative Care Unit, Department of Radiology, University Areteion Hospital School of Medicine, 27 Korinthias Str., 115 26, Athens, Greece.
Support Care Cancer. 2004 Dec;12(12):821-5. doi: 10.1007/s00520-004-0698-y. Epub 2004 Oct 6.
The aim of the present study was to validate the Greek version of the Hospital Anxiety and Depression Scale (HAD) in a palliative care unit.
The scale was translated with the "forward-backward" procedure to Greek. It was administered twice, with a 1-week interval, to 120 patients with advanced cancer. Together with the HAD scale, the patients also completed the Spielberger State-Anxiety Scale (STAI-S).
Factor analyses identified a two-factor solution corresponding to the original two subscales of the HAD, which were found to be correlated. The Greek version of the HAD had Cronbach's alphas for the anxiety and depression scales of 0.887 and 0.703, respectively. Validity as performed using known-group analysis showed good results. Both anxiety and depression subscales discriminated well between subgroups of patients differing in disease severity as defined by ECOG performance status. Correlations between the HAD scale and the STAI-S was 0.681 for the anxiety subscale and 0.485 for the depression subscale.
These psychometric properties of the Greek version of the HAD scale confirm it as a valid and reliable measure when administered to patients with advanced cancer.
本研究的目的是在一家姑息治疗病房验证希腊语版的医院焦虑抑郁量表(HAD)。
该量表通过“前后”程序翻译成希腊语。对120例晚期癌症患者进行了两次测量,间隔1周。患者除完成HAD量表外,还完成了斯皮尔伯格状态焦虑量表(STAI-S)。
因子分析确定了一个与HAD原始两个子量表相对应的两因子解决方案,发现这两个子量表具有相关性。希腊语版HAD焦虑量表和抑郁量表的克朗巴赫α系数分别为0.887和0.703。使用已知组分析进行的效度检验显示结果良好。焦虑和抑郁子量表在根据东部肿瘤协作组(ECOG)体能状态定义的疾病严重程度不同的患者亚组之间有良好的区分度。HAD量表与STAI-S的焦虑子量表相关性为0.681,抑郁子量表相关性为0.485。
希腊语版HAD量表的这些心理测量学特性证实,该量表应用于晚期癌症患者时是一种有效且可靠的测量工具。